Skip to main content
Erschienen in: The Indian Journal of Pediatrics 11/2016

09.06.2016 | Review Article

Ascites in Children

verfasst von: Ashish Bavdekar, Nitin Thakur

Erschienen in: Indian Journal of Pediatrics | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Ascites is an accumulation of serous fluid within the peritoneal cavity. It is the most common complication of liver cirrhosis. In children, hepatic, renal and cardiac disorders are the most common causes. Portal hypertension and sodium and fluid retention are key factors in the pathophysiology of ascites. Peripheral arterial vasodilatation hypothesis is the most accepted mechanism for inappropriate sodium retention and formation of ascites. Diagnostic paracentesis is indicated in children with newly diagnosed ascites and in children with suspected complications of ascites. Ascitic fluid is evaluated for cell count, protein level, and culture. The serum-ascites albumin gradient (SAAG) is the best single test for classifying ascites into portal hypertensive (SAAG >1.1 g/dl) and non–portal hypertensive (SAAG <1.1 g/dl). A neutrophil count ≥250 cells/mm3 is highly suggestive of bacterial peritonitis. The treatment of ascites due to non-liver disease depends on the underlying condition. In liver disease, diuretics as monotherapy or dual therapy and salt restriction form the mainstay of treatment in children with mild to moderate ascites. Fluid restriction is helpful in children with hyponatremia. In non-responsive ascites or in children with large ascites, large volume paracentesis (LVP) with albumin infusion should be performed. In children with refractory ascites, LVP with albumin administration, transjugular intrahepatic porto-systemic shunt (TIPS), peritoneo-venous shunting and liver transplantation are other therapeutic modalities that need to be considered.
Literatur
1.
Zurück zum Zitat Kennedy M, Liacouras CA. Ascitis. In: Kliegman RM, Stanton BF, Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. New Delhi: Elsevier Saunders; 2012. p. 5041–4. Kennedy M, Liacouras CA. Ascitis. In: Kliegman RM, Stanton BF, Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. New Delhi: Elsevier Saunders; 2012. p. 5041–4.
2.
Zurück zum Zitat Sankaranarayanan VS. Ascites in children. In: Bavdekar AR, Mathai J, Malathi S, Yachha SK, editors. IAP Speciality series on pediatric gastroenterology. New Delhi: Jaypee; 2013. p. 270–80.CrossRef Sankaranarayanan VS. Ascites in children. In: Bavdekar AR, Mathai J, Malathi S, Yachha SK, editors. IAP Speciality series on pediatric gastroenterology. New Delhi: Jaypee; 2013. p. 270–80.CrossRef
3.
Zurück zum Zitat McKiernan PJ. The acutely ill baby. In: Kelly D, editor. Diseases of the liver and biliary system in children. Birmingham: Wiley-Blackwell; 2008. p. 106–26. McKiernan PJ. The acutely ill baby. In: Kelly D, editor. Diseases of the liver and biliary system in children. Birmingham: Wiley-Blackwell; 2008. p. 106–26.
4.
Zurück zum Zitat Garcia-Tsao G. Ascitis. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock’s disease of the liver and biliary system. Birmingham: Wiley-Blackwell; 2011. p. 210–33.CrossRef Garcia-Tsao G. Ascitis. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock’s disease of the liver and biliary system. Birmingham: Wiley-Blackwell; 2011. p. 210–33.CrossRef
5.
Zurück zum Zitat Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis—a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.CrossRefPubMed Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis—a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.CrossRefPubMed
6.
Zurück zum Zitat Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology. 2002;35:478–91.CrossRefPubMed Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology. 2002;35:478–91.CrossRefPubMed
7.
Zurück zum Zitat European Association for the Study of Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef European Association for the Study of Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef
8.
Zurück zum Zitat Oelsner DH, Caldwell SH, Coles M, Driscoll CJ. Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy. Gastrointest Endosc. 1998;47:388–90.CrossRefPubMed Oelsner DH, Caldwell SH, Coles M, Driscoll CJ. Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy. Gastrointest Endosc. 1998;47:388–90.CrossRefPubMed
9.
Zurück zum Zitat Shepherd R. Complications and management of chronic liver disease. In: Kelly D, editor. Diseases of the liver and biliary system in children. Birmingham: Wiley-Blackwell; 2008. p. 351–78. Shepherd R. Complications and management of chronic liver disease. In: Kelly D, editor. Diseases of the liver and biliary system in children. Birmingham: Wiley-Blackwell; 2008. p. 351–78.
10.
Zurück zum Zitat Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000;32:142–53.CrossRefPubMed Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000;32:142–53.CrossRefPubMed
11.
Zurück zum Zitat Larcher VF, Manolaki N, Vegnent A, et al. Spontaneous bacterial peritonitis with chronic liver disease: clinical features and etiologic factors. J Pediatr. 1985;106:907–12.CrossRefPubMed Larcher VF, Manolaki N, Vegnent A, et al. Spontaneous bacterial peritonitis with chronic liver disease: clinical features and etiologic factors. J Pediatr. 1985;106:907–12.CrossRefPubMed
12.
Zurück zum Zitat Albillos A, Cuervas-Mons V, Millan I, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 1990;98:134–40.CrossRefPubMed Albillos A, Cuervas-Mons V, Millan I, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 1990;98:134–40.CrossRefPubMed
13.
Zurück zum Zitat Runyon BA, Antillon MR, Akriviadis EA, McHuchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol. 1990;28:2811–2.PubMedPubMedCentral Runyon BA, Antillon MR, Akriviadis EA, McHuchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol. 1990;28:2811–2.PubMedPubMedCentral
14.
Zurück zum Zitat Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–20.CrossRefPubMed Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–20.CrossRefPubMed
15.
16.
Zurück zum Zitat Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–8.CrossRefPubMed Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–8.CrossRefPubMed
17.
Zurück zum Zitat Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005;25:57–61.CrossRefPubMed Cholongitas E, Papatheodoridis GV, Lahanas A, et al. Increasing frequency of gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005;25:57–61.CrossRefPubMed
18.
Zurück zum Zitat Narula N, Tsoi K, Marshall JK. Should albumin be used in all patients with spontaneous bacterial peritonitis? Can J Gastroenterol. 2011;25:373–6.CrossRefPubMedPubMedCentral Narula N, Tsoi K, Marshall JK. Should albumin be used in all patients with spontaneous bacterial peritonitis? Can J Gastroenterol. 2011;25:373–6.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716–24.CrossRefPubMed Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716–24.CrossRefPubMed
20.
Zurück zum Zitat Pérez-Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology. 1983;84:961–8.PubMed Pérez-Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology. 1983;84:961–8.PubMed
21.
Zurück zum Zitat Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–56.CrossRefPubMed Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–56.CrossRefPubMed
22.
Zurück zum Zitat Kramer RE, Sokol RJ, Yerushalmi B, et al. Large-volume paracentesis in the management of ascites in children. J Pediatr Gastroenterol Nutr. 2001;33:245–9.CrossRefPubMed Kramer RE, Sokol RJ, Yerushalmi B, et al. Large-volume paracentesis in the management of ascites in children. J Pediatr Gastroenterol Nutr. 2001;33:245–9.CrossRefPubMed
23.
Zurück zum Zitat Ginès A, Fernandez-Esparrach G, Monescillo A, et al. Randomized controlled trial comparing albumin, dextran-70 and polygelin in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111:1002–10.CrossRefPubMed Ginès A, Fernandez-Esparrach G, Monescillo A, et al. Randomized controlled trial comparing albumin, dextran-70 and polygelin in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111:1002–10.CrossRefPubMed
24.
Zurück zum Zitat Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23:164–76.CrossRefPubMed Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23:164–76.CrossRefPubMed
25.
Zurück zum Zitat D’Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–93.CrossRefPubMed D’Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–93.CrossRefPubMed
26.
Zurück zum Zitat Albillos A, Banares R, Gonzalez M, et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005;43:990–6.CrossRefPubMed Albillos A, Banares R, Gonzalez M, et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol. 2005;43:990–6.CrossRefPubMed
27.
Zurück zum Zitat Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.CrossRefPubMed Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.CrossRefPubMed
28.
Zurück zum Zitat Moore KP, Wong F, Ginès P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.CrossRefPubMed Moore KP, Wong F, Ginès P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.CrossRefPubMed
29.
Zurück zum Zitat Dumortier J, Pianta E, Le Derf Y, et al. Peritoneovenous shunt as a bridge to liver transplantation. Am J Transplant. 2005;5:1886–92.CrossRefPubMed Dumortier J, Pianta E, Le Derf Y, et al. Peritoneovenous shunt as a bridge to liver transplantation. Am J Transplant. 2005;5:1886–92.CrossRefPubMed
Metadaten
Titel
Ascites in Children
verfasst von
Ashish Bavdekar
Nitin Thakur
Publikationsdatum
09.06.2016
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 11/2016
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-016-2168-1

Weitere Artikel der Ausgabe 11/2016

The Indian Journal of Pediatrics 11/2016 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.